gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/244;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/312;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ED/121;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ED/132;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ED/139;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/NT/100;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/NT/115;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/NT/117;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=OCCAMS/NT/101;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/NT/107;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/334;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/QE/148;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/QE/111;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/QE/079;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ST/081;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ST/101;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=OCCAMS/AH/338;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=OCCAMS/AH/292;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=AHM1388;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=BEST2/UCL/0261;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=AHM0389;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=AHM1495;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=AHM1594;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=AHM1240;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=BEST2/CAM/0513;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=BEST2/NOT/0003;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=AHM1433;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=BEST2/UCL/0032;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=BEST2/CAM/0431;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=BEST2/NEW/0097;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=BEST2/CAM/0465;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=BEST2/NOT/0011;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=BEST2/POR/0028;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=BEST2/CAM/0158;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=BEST2/UCL/0136;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=AHM1563;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=BEST2/NOT/0087;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=AHN01396;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=AHM0702;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=AHM0062;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=AHM0860;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=AHM0931;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=AHM0432;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=AHM0694;ENA-CHECKLIST=ERC000026;
